Evidence map›Paper›PMID 34266476›Full record

ArticleIsrael journal of health policy research2021

National and regional trends in MRI utilization in the face of the ongoing COVID-19 pandemic.

Osnat Luxenburg, Mor Saban, Vicki Myers, Sharona Vaknin, Noga Boldor, Rachel Wilf-Miron

Abstract read
In one paragraph

Article in Israel journal of health policy research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Osnat LuxenburgMedical Technology, Health Information and Research Directorate, Ministry of Health, Jerusalem, Israel.
Mor SabanThe Gertner Institute for Epidemiology and Health Policy Research, Sheba Medical Center, 1 Emek dotan Street, 5262100, Ramat-Gan, Israel. morsab1608@gmail.com.
Vicki MyersThe Gertner Institute for Epidemiology and Health Policy Research, Sheba Medical Center, 1 Emek dotan Street, 5262100, Ramat-Gan, Israel.
Sharona VakninThe Gertner Institute for Epidemiology and Health Policy Research, Sheba Medical Center, 1 Emek dotan Street, 5262100, Ramat-Gan, Israel.
Noga BoldorThe Gertner Institute for Epidemiology and Health Policy Research, Sheba Medical Center, 1 Emek dotan Street, 5262100, Ramat-Gan, Israel.
Rachel Wilf-MironThe Gertner Institute for Epidemiology and Health Policy Research, Sheba Medical Center, 1 Emek dotan Street, 5262100, Ramat-Gan, Israel.ORCID 0000-0002-8112-8721

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeMarked reductions in imaging exams have been documented during the COVID-19 pandemic. The study aimed to examine the effect of the two waves of COVID-19 on magnetic resonance imaging (MRI) utilization at the national and regional level. MATERIALS AND

methodsA retrospective-archive study was conducted in Israel, comparing March-December 2020 with March-December 2018 and 2019. Data on MRI utilization were obtained from the national MRI registry, while data on confirmed COVID-19 cases, by place of residence, were obtained from the Israeli Ministry of Health open COVID-19 database.

resultsThe number and rate of MRI examinations decreased during the first COVID-19 wave, with the steepest drop in April 2020: 47.5% relative decrease compared to April 2019, and 42.2% compared to 2018. This was followed by a compensatory increase between the waves and a return to almost pre-pandemic levels of use, with just a modest decrease, during the second, more intense COVID wave, compared with the previous year. Existing differences between regions increased during the pandemic. The rate ratio of MRI exams between Tel-Aviv and the Northern periphery increased from 2.89 in April 2019 to 3.94 in April 2020. Jerusalem metropolitan region, with the largest burden of COVID disease, demonstrated only a modest decrease (1%) in MRI utilization during the first 10 months of the pandemic.

conclusionsAt the national level, time trends in reduced MRI utilization followed the first wave of COVID-19, and were accompanied by increased regional disparities. These changes were not explained by differences in the burden of COVID-19 disease but might be explained by unequal distribution of MRI scanners among regions. Reduced utilization was not evident during the second wave, nor at the beginning of the third wave, despite higher COVID-19 case load, demonstrating adaptation to the new normal. Patterns of MRI utilization might help policy-makers and healthcare managers predict the behavior of imaging as well as other sectors, such as elective surgical procedures, during an ongoing pandemic. This forecast might help to manage the lasting effects of the pandemic, including extended waiting times, in the months and years following its remission. In preparation for future national emergencies, timely and detailed data on MRI utilization can serve as a "sensor" for a wide array of diagnostic and interventional medical activities, providing policy-makers with an updated snapshot to guide their response at the regional and national levels.

Indexed as

PandemicsCOVID-19HumansIsraelMagnetic Resonance ImagingProcedures and Techniques UtilizationRetrospective StudiesCOVID-19PandemicWave, Disparity, MRI exam

Identifiers

PMID34266476
PMCPMC8280577

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.